Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
出版年份 2020 全文链接
标题
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
作者
关键词
-
出版物
Immunotherapy
Volume 12, Issue 5, Pages 269-273
出版商
Future Medicine Ltd
发表日期
2020-03-26
DOI
10.2217/imt-2020-0067
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients
- (2020) Melissa Bersanelli et al. Immunotherapy
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Clinical trial analysis of 2019‐nCoV therapy registered in China
- (2020) Qi Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
- (2020) Vincent J. Munster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Immune Checkpoint Inhibitor Therapy–related Pneumonitis: Patterns and Management
- (2019) Kevin R. Kalisz et al. RADIOGRAPHICS
- A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
- (2019) Alessio Cortellini et al. SEMINARS IN ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study
- (2018) Melissa Bersanelli et al. Immunotherapy
- A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy
- (2018) Alice Horisberger et al. Journal for ImmunoTherapy of Cancer
- Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
- (2017) Seth J. Rotz et al. PEDIATRIC BLOOD & CANCER
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology
- (2013) Sarah N. Lauder et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now